Back to Search
Start Over
Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
- Source :
-
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2016 Sep 20; Vol. 113 (38), pp. E5675-84. Date of Electronic Publication: 2016 Sep 06. - Publication Year :
- 2016
-
Abstract
- Design of ligands that provide receptor selectivity has emerged as a new paradigm for drug discovery of G protein-coupled receptors, and may, for certain families of receptors, only be achieved via identification of chemically diverse allosteric modulators. Here, the extracellular vestibule of the M2 muscarinic acetylcholine receptor (mAChR) is targeted for structure-based design of allosteric modulators. Accelerated molecular dynamics (aMD) simulations were performed to construct structural ensembles that account for the receptor flexibility. Compounds obtained from the National Cancer Institute (NCI) were docked to the receptor ensembles. Retrospective docking of known ligands showed that combining aMD simulations with Glide induced fit docking (IFD) provided much-improved enrichment factors, compared with the Glide virtual screening workflow. Glide IFD was thus applied in receptor ensemble docking, and 38 top-ranked NCI compounds were selected for experimental testing. In [(3)H]N-methylscopolamine radioligand dissociation assays, approximately half of the 38 lead compounds altered the radioligand dissociation rate, a hallmark of allosteric behavior. In further competition binding experiments, we identified 12 compounds with affinity of ≤30 μM. With final functional experiments on six selected compounds, we confirmed four of them as new negative allosteric modulators (NAMs) and one as positive allosteric modulator of agonist-mediated response at the M2 mAChR. Two of the NAMs showed subtype selectivity without significant effect at the M1 and M3 mAChRs. This study demonstrates an unprecedented successful structure-based approach to identify chemically diverse and selective GPCR allosteric modulators with outstanding potential for further structure-activity relationship studies.<br />Competing Interests: A patent on “new allosteric modulators of the M2 muscarinic receptor” has been filed based on findings presented in this study.
- Subjects :
- Allosteric Regulation
Allosteric Site
Animals
Binding, Competitive drug effects
CHO Cells
Cricetulus
Humans
Kinetics
Lead pharmacology
Ligands
Molecular Docking Simulation
Molecular Dynamics Simulation
Protein Conformation drug effects
Radioligand Assay
Receptor, Muscarinic M1 agonists
Receptor, Muscarinic M1 antagonists & inhibitors
Receptor, Muscarinic M1 chemistry
Receptor, Muscarinic M2 chemistry
Receptor, Muscarinic M3 agonists
Receptor, Muscarinic M3 antagonists & inhibitors
Receptor, Muscarinic M3 chemistry
Lead chemistry
Receptor, Muscarinic M2 agonists
Receptor, Muscarinic M2 antagonists & inhibitors
Structure-Activity Relationship
Subjects
Details
- Language :
- English
- ISSN :
- 1091-6490
- Volume :
- 113
- Issue :
- 38
- Database :
- MEDLINE
- Journal :
- Proceedings of the National Academy of Sciences of the United States of America
- Publication Type :
- Academic Journal
- Accession number :
- 27601651
- Full Text :
- https://doi.org/10.1073/pnas.1612353113